Article Detail - JF Part A
Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (A59522) - R2 - Effective July 1, 2024
Date Posted: July 11, 2024
This Local Coverage Article (LCA) has been revised under contractor numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).
Effective Date: July 1, 2024
Summary of Changes:
Under CPT/HCPCS Codes Group 1: Codes added 0456U. This is due to the 2024 Q3 CPT/HCPCS Code Update and is effective 7/1/2024.
Under Article Text revised 3rd and 6th bullets to remove "DEX Z-Code™" and replaced with "DEX Z-Code®". Added "NOTE: When entering the DEX Z-Code® on the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line".
This revision is due to the 2024 Q3 CPT/HCPCS Code Update and is effective 7/1/2024.
Visit the Noridian Active LCDs webpage to view the document or access it via the CMS MCD.